1 for the development of clinical practice guidelines
that considers future emerging evidence. Changes in the evidence base necessitate subsequent updated recommendations. Recently, a report of a randomized controlled trial2
that compared ramipril to a matching placebo was retracted.3
The trial had shown that 10 mg/d of ramipril given for 24
weeks to patients with intermittent claudication (IC)
increased mean pain-free walking time, maximum walking
time, Walking Impairment